Ovid Therapeutics to Present at Upcoming August Investor Conferences

Investor Relations: Garret Bonney 617-735-6093 IR@ovidrx.com NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by certain epilepsies and brain conditions, today announced that management will participate in two upcoming investor conferences in August: Live webcasts of the fireside chat and panel discussion can be accessed through the Events & Presentations section of the Company's we ...